The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19.

COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey

Francesco Bianco;Valentina Bucciarelli;
2020

Abstract

The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19.
File in questo prodotto:
File Dimensione Formato  
jcm-09-01774.pdf

accesso aperto

Descrizione: Article
Tipologia: PDF editoriale
Dimensione 862.3 kB
Formato Adobe PDF
862.3 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11564/725220
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 40
social impact